Autologous CAR-T/TCR-T Cell Immunotherapy for Malignancies

计划入组 73 人 · 首次发布于 2018 年 8 月 20 日

Autologous CAR-T/TCR-T Cell Immunotherapy for Solid Malignancies

计划入组 50 人 · 首次发布于 2019 年 5 月 8 日

Clinical Study on the EBV CAR-T /TCR-T Cells in the Treatment of Nasopharyngeal Carcinoma

计划入组 24 人 · 首次发布于 2022 年 10 月 20 日

Tri-modal CAR+TCR+hnCD16+iPSC-derived T cells(Fate)

TCR-like CAR-T Cell Therapy(Zhongda Hospital Southeast University)

IL13Rα2 CAR-T(TCR CURE Biopharma)

LION TCR PTE. LTD.

Singapore

Mister Car Wash

United States

JOHN LENEHAN

Australia

Poseida Therapeutics Presents Promising Data on Allogeneic CAR-T Therapies for Hematologic Cancers and Solid Tumors

Bracco Launches BubbleGen CD3+ T Cell Selection Kit for Bead-Free Cell Therapy Manufacturing

Aera Therapeutics Nominates AERA-109 as First Development Candidate for In Vivo CAR-T Therapy